NASSIF DAVID W. enters SIO GENE THERAPIES INC. with 9.15K shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 7/2/2019ACC: 0001209191-19-040473
Officer· Principal Financial Officer
Since Jul 2019
9.15K
Baseline shares
100% direct
9.15K
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Shares
DirectShares owned9.15K
Total
9.15K direct9.15K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 9.15K | Direct |
| Total | 9.15K | 9.15K direct |
Derivative Holdings0
No derivative holdings reported